Grown Rogue International (GRUSF) EBT (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly EBT came in at -$1.7 million in Q1 2026, down 223.46% year-on-year from $1.4 million in Q1 2025, and up 100.0% quarter-over-quarter from -$5914.4 billion in Q4 2025.
Grown Rogue International (GRUSF) EBT (2009 - 2026) Analysis & Trends
Grown Rogue International's EBT history runs 17 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- On a quarterly basis, EBT fell 223.46% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$3002.5 billion, a 127.76% decrease from a year earlier, with the FY2025 full-year figure at -$513323.0, down 170.95% from the prior year.
- EBT rose to -$1.7 million in Q1 2026 per GRUSF's latest filing, from -$5914.4 billion in the prior quarter.
- Across five years, EBT topped out at $11224.9 billion in Q4 2024 and bottomed at -$5914.4 billion in Q4 2025.
- The 5-year median for EBT is $192459.0 (2022), against an average of $520.9 billion.
- Across the five-year window, EBT jumped 1669307656.58% in 2024 and tumbled 223.46% in 2026, its largest moves.
- Year by year, EBT stood at $192459.0 in 2022, then tumbled by 449.39% to -$672427.0 in 2023, then soared by 1669307656.58% to $11224.9 billion in 2024, then tumbled by 152.69% to -$5914.4 billion in 2025, then soared by 100.0% to -$1.7 million in 2026.
- Per Business Quant, the three latest GRUSF EBT figures stand at -$1.7 million (Q1 2026), -$5914.4 billion (Q4 2025), and $2912.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | -5,914.43 Bn |
| Sep 30, 2025 | 2,911.96 Bn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 11,224.87 Bn |
| Sep 30, 2024 | -408.36 Bn |
| Jun 30, 2024 | -5.13 Mn |
| Mar 31, 2024 | -3.80 Mn |
| Dec 31, 2023 | -672,427.00 |
| Oct 31, 2023 | -958,679.00 |
| Jul 31, 2023 | 1.06 Mn |
| Apr 30, 2023 | 631,938.00 |
| Jan 31, 2023 | 667,291.00 |
| Jan 31, 2022 | 192,459.00 |
| Oct 31, 2021 | 1.62 Mn |
| Jul 31, 2021 | 764,360.00 |
| Apr 30, 2021 | -586,589.00 |
| Jan 31, 2021 | -995,593.00 |
| Oct 31, 2020 | -3.55 Mn |